97 related articles for article (PubMed ID: 32813838)
1. FoxP3+ regulatory T cells in oral tongue squamous cell carcinoma in young and older patients.
Amaral MGD; Sena LSB; Batista AC; MendonÇa EF; GordÓn-NÚÑez MA; Alves PM; Nonaka CFW
Braz Oral Res; 2020; 34():e096. PubMed ID: 32813838
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of FoxP3+ regulatory T cells in lower lip squamous cell carcinomas.
da Cunha FA; Aguiar MC; Souza LB; Pinto LP; Godoy GP; Alves PM; Nonaka CF
Braz Oral Res; 2016 Dec; 30(1):e130. PubMed ID: 28001240
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of HLA-G and FoxP3+ T regulatory cells in oral cavity and lower lip squamous cell carcinomas.
Gonzaga AKG; Santos HBP; Crispim JCO; Souza LB; Palomino GM
Braz Oral Res; 2019; 33():e020. PubMed ID: 30994705
[TBL] [Abstract][Full Text] [Related]
4. TIPE2 suppresses progression and tumorigenesis of the oral tongue squamous cell carcinoma by regulating FoxP3
Zhao LL
J Bioenerg Biomembr; 2020 Aug; 52(4):279-289. PubMed ID: 32594290
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of lymphatic vessel density and mast cells in oral tongue squamous cell carcinoma.
Mafra RP; Serpa MS; Lima KC; Silveira ÉJDD; Souza LB; Pinto LP
J Craniomaxillofac Surg; 2018 Dec; 46(12):2234-2239. PubMed ID: 30482715
[TBL] [Abstract][Full Text] [Related]
7. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.
Shen X; Li N; Li H; Zhang T; Wang F; Li Q
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638
[TBL] [Abstract][Full Text] [Related]
9. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.
Ding L; Zhang Z; Shang D; Cheng J; Yuan H; Wu Y; Song X; Jiang H
J Oral Pathol Med; 2014 May; 43(5):335-43. PubMed ID: 24313357
[TBL] [Abstract][Full Text] [Related]
10. Expressions of Immune Negative Regulator FoxP3+Treg and PD-L1 Protein in the Immune Microenvironment of Cervical Lesion.
Ma Q; Zhao M; Wei X; Zhao J; Yang T; Zhang Q; Wang K; Yang X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):128-132. PubMed ID: 28270295
[TBL] [Abstract][Full Text] [Related]
11. Oral tongue squamous cell carcinoma survival as stratified by age and sex: A surveillance, epidemiology, and end results analysis.
Mukdad L; Heineman TE; Alonso J; Badran KW; Kuan EC; St John MA
Laryngoscope; 2019 Sep; 129(9):2076-2081. PubMed ID: 30575045
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
[TBL] [Abstract][Full Text] [Related]
13. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells.
Zhou X; Su YX; Lao XM; Liang YJ; Liao GQ
Oral Oncol; 2016 Feb; 53():27-35. PubMed ID: 26631955
[TBL] [Abstract][Full Text] [Related]
14. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
[TBL] [Abstract][Full Text] [Related]
15. p53 Expression Helps Identify High Risk Oral Tongue Pre- malignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases.
Viveka TS; Shyamsundar V; Krishnamurthy A; Ramani P; Ramshankar V
Asian Pac J Cancer Prev; 2016; 17(1):189-95. PubMed ID: 26838208
[TBL] [Abstract][Full Text] [Related]
16. Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma.
Boxberg M; Leising L; Steiger K; Jesinghaus M; Alkhamas A; Mielke M; Pfarr N; Götz C; Wolff KD; Weichert W; Kolk A
J Immunol; 2019 Jan; 202(1):278-291. PubMed ID: 30530592
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cancer cell-derived Foxp3 and tumor microenvironment in human tongue squamous cell carcinoma.
Li K; Huang SH; Lao XM; Yang L; Liao GQ; Liang YJ
Exp Cell Res; 2018 Sep; 370(2):643-652. PubMed ID: 30040923
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the presence of Th1 response through T-bet and IFN-gamma immunohistochemical expression in lower lip and oral tongue squamous cell carcinomas.
Rodrigues RR; Freitas VS; Alves PM; Almeida Freitas R; Souza LB; Andrade Santos PP
Pathol Res Pract; 2024 Jan; 253():155010. PubMed ID: 38101155
[TBL] [Abstract][Full Text] [Related]
19. Histological characteristics of early-stage oral tongue cancer in young versus older patients: A multicenter matched-pair analysis.
Bello IO; Almangush A; Heikkinen I; Haglund C; Coletta RD; Kowalski LP; Mäkitie AA; Nieminen P; Leivo I; Salo T
Oral Dis; 2020 Jul; 26(5):1081-1085. PubMed ID: 31994277
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
